Sorafenib's safety and efficacy are similar in elderly and younger patients treated for hepatocellular carcinomaJ. Edeline,L. Crouzet,S. Lesourd,A. Brunot,F. Le Roy,C. Cattenoz,M. Latournerie,D. Gedouin,A. Guillygomarc'h,E. BoucherEUROPEAN JOURNAL OF CANCER(2013)引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要